Longevity of the novel ConvaTec infusion set with Lantern technology

A Prospective Study of Insulin Infusion Set Use for up to 7 Days: Early Replacement Reasons and Impact on Glycemic Control

(2020) Delia Waldenmaier et al.   Diabetes Technology & Therapeutics

Development of a Single-Site Device for Conjoined Glucose Sensing and Insulin Delivery in Type-1 Diabetes Patients

(2019) Mathias Tschaikner et al.   IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING

Novel Single-Site Device for Conjoined Glucose Sensing and Insulin Infusion: Performance Evaluation in Diabetes Patients During Home-Use

(2019) Mathias Tschaikner et al.   IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING

Fatalities Due to Failure of Continuous Subcutaneous Insulin Infusion Devices: A Report of Six Cases

(2018) Andrew Ziegler et al.   JOURNAL OF FORENSIC SCIENCES

Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes

(2016) Andrew W. Karlin et al.   Diabetes Technology & Therapeutics

Randomized Trial of Infusion Set Function: Steel Versus Teflon

(2013) Parul J. Patel et al.   Diabetes Technology & Therapeutics

Consequences of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion

(2009) Tina K. Thethi et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS